Effect of royal jelly on experimental colitis induced by acetic acid and alteration of mast cell distribution in the colon of rats

European Journal of Histochemistry

Volumn 54, Issue 4, 2010, Pages 158-161

  Karaca, T ^a   Bayiroglu, F ^a   Yoruk, M ^a   Kaya, M S ^a   Uslu, S ^a   Comba, B ^a   Mis, L ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

Colitis; Mast cell; Rat; Royal jelly

Indexed keywords

ANIMALIA; RATTUS;

EID: 78249241779     PISSN: 1121760X     EISSN: None     Source Type: Journal    
DOI: 10.4081/ejh.2010.e35     Document Type: Article

References (38)

1. Porath D, Riegger C, Drewe J, Schwager J. Epigallocatechin-3-gallate impairs che - mokine production in human colon epithelial cell lines. J Pharmacol Exp Ther 2005; 315:1172-80.
2. Chen C, Shen G, Hebbar V, Hu R, Owuor ED, Kong AN. Epigallocatechin-3-gallate-indu - ced stress signals in HT-29 human colon adenocarcinoma cells. Carcinogenesis 2003; 24:1369-78.
3. Katiyar SK, Mukhtar H. Tea antioxidants in cancer chemoprevention. J Cell Biochem Suppl 1997;27:59-67.
4. Kanbur M, Eraslan G, Beyaz L, Silici S, Liman BC, Altinordulu et al. The effects of royal jelly on liver damage induced by paracetamol in mice. Exp Toxicol Pathol 2009;61:123-32.
5. Karaali A, Meydanoglu F, Eke D. Studies on composition, freeze-drying and storage of Turkish royal jelly. J Apic Res 1998;27:182-5.
6. Bloodworth BC, Harn CS, Hock CT, Boon YO. Liquid chromatographic determination of trans-10-hydroxy-2-decenoic acid content of commercial products containing royal jelly. J AOAC Int 1995;78:1019-23.
7. Taniguchi Y, Kohno K, Inoue S, Koya-Miyata S, Okamoto I, Arai N et al. Oral administration of royal jelly inhibits the development of atopic dermatitis-like skin lesions in NC/Nga mice. Int Immunopharmacol 2003; 3:1313-24.
8. Okamoto I, Taniguchi Y, Kunikata T, Kohno K, Iwaki K, Ikeda M et al. Major royal jelly protein 3 modulates immune responses in vitro and in vivo. Life Sci 2003;73:2029-45.
9. El-Nekeety AA, El-Kholy W, Abbas NF, Ebaid A, Amra HA, Abdel-Wahhab MA. Efficacy of royal jelly against the oxidative stress of fumonisin in rats. Toxicon 2007;50:256-69.
10. Bischoff SC, Wedemeyer J, Herrmann A, Meier PN, Trautwein C, Cetin Y et al. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology 1996; 28:1-13.
11. Lorentz A, Schwengberg S, Mierke C, Manns MP, Bischoff SC. Human intestinal mast cells produce IL-5 in vitro upon IgE receptor cross-linking and in vivo in the course of intestinal inflammatory disease. Eur J Immunol 1999;29:1496-503.
12. Gelbmann CM, Mestermann S, Gross V, Kollinger M, Scholmerich J, Falk W. Strictures in Crohn's disease are characterised by an accumulation of mast cells colocalised with laminin but not with fibronectin or vitronectin. Gut 1999;45: 210-7.
13. Bischoff SC, Lorentz A, Schwengberg S, Weier G, Raab R, Manns MP. Mast cells are an important cellular source of tumour necrosis factor alpha in human intestinal tissue. Gut 1999;44:643-52.
14. Inamura H, Kashiwase Y, Morioka J, Suzuki K, Igarashi Y, Kurosawa M. Accumulation of mast cells in the interstitium of eosinophilic colitis. Allergol Immunopathol (Madr) 2006;34:228-30.
15. Kashiwase PY, Inamura H, Morioka J, Igarashi Y, Kawai-Kowase K, Kurosawa M. Quantitative analysis of mast cells in benign and malignant colonic lesions: Immunohistochemical study on formalinfixed, paraffin-embedded tissues. Allergol Immunopathol (Madr) 2008;36:271-6.
16. Bischoff SC, Schwengberg S, Wordelmann K, Weimann A, Raab R, Manns MP. Effect of c-kit ligand, stem cell factor, on mediator release by human intestinal mast cells isolated from patients with inflammatory bowel disease and controls. Gut 1996;38: 104-14.
17. Sellge G, Bischoff SC. Isolation, culture, and characterization of intestinal mast cells. Methods Mol Biol 2006;315:123-38.
18. Kang JW, Kim TW, La JH, Sung TS, Kim HJ, Kwon YB et al. Electroacupuncture ameliorates experimental colitis induced by acetic acid in rat. J Vet Sci 2004;5:189-95.
19. Fakhfouri G, Rahimian R, Daneshmand A, Bahremand A, Rasouli MR, Dehpour AR et al. Granisetron ameliorates acetic acidinduced colitis in rats. Hum Exp Toxicol 2010;29:321-8.
20. Enerback L. Mast cell heterogeneity: the evolution of the concept of a specific mucosal mast cell. In mast cell differentiation and heterogeneity, edited by Befus AD, Bienenstock J, Denburg JA, New York, Raven Press, USA, 1986.
21. Nieto N, Torres MI, Rios A, Gil A. Dietary polyunsaturated fatty acids improve histological and biochemical alterations in rats with experimental ulcerative colitis. J Nutr 2002;132:11-9.
22. Kerem Z, Chetrit D, Shoseyov O, Regev- Shoshani G. Protection of lipids from oxidation by epicatechin, trans-resveratrol, and gallic and caffeic acids in intestinal model systems. J Agric Food Chem 2006; 54:10288-93.
23. Almaraz-Abarca N, da Graça Campos M, Avila-Reyes JA, Naranjo-Jiménez N, Herrera Corral J, Gonzalez-Valdez LS. Antioxidant activity of polyphenolic extract of monofloral honeybee collected pollen from mesquite (Prosopis juliflora, Leguminosae). J Food Compost Anal 2007; 20:119-124.
24. Wu Y, Zhou C, Li X, Song L, Wu X, Lin W et al. Evaluation of antiinflammatory activity of the total flavonoids of Laggera pterodonta on acute and chronic inflammation models. Phytother Res 2006;20:585-90.
25. Fiorani M, Accorsi A, Blasa M, Diamantini G, Piatti E. Flavonoids from italian multifloral honeys reduce the extracellular ferricyanide in human red blood cells. J Agric Food Chem 2006;54:8328-34.
26. El-Dakhakhny M, Barakat M, Abd El-Halim M, Aly SM. Effects of Nigella sativa oil on gastric secretion and ethanol induced ulcer in rats. J Ethnopharmacol 2000;72: 299-304.
27. Kohno K, Okamoto I, Sano O, Arai N, Iwaki K, Ikeda M et al. Royal jelly inhibits the production of proinflammatory cytokines by activated macrophages. Biosci Biotechnol Biochem 2004;68:138-45.
28. Nakaya M, Onda H, Sasaki K, Yukiyoshi A, Tachibana H, Yamada K. Effect of royal jelly on bisphenol A-induced proliferation of human breast cancer cells. Biosci Biotechnol Biochem 2007;71:253-5.
29. Fujii A. Pharmacological effect of royal jelly. Honeybee Sci 1995;16:97-104.
30. Hamerlinck FF. Neopterin: a review. Exp Dermatol 1999;8:167-76.
31. Oka H, Emori Y, Kobayashi N, Hayashi Y, Nomoto K. Suppression of allergic reactions by royal jelly in association with the restoration of macrophage function and the improvement of Th1/Th2 cell responses. Int Immunopharmacol 2001;1:521-32.
32. Kamakura M, Maebuchi M, Ozasa S, Komori M, Ogawa T, Sakaki T et al. Influence of royal jelly on mouse hepatic gene expression and safety assessment with a DNA microarray. J Nutr Sci Vitaminol (Tokyo) 2005;51:148-55.
33. Kahraman A, Erkasap N, Köken T, Serteser M, Aktepe F, Erkasap S. The antioxidative and antihistaminic properties of quercetin in ethanol-induced gastric lesions. Toxicology 2003;183:133-42.
34. Kanter M, Coskun O, Uysal H. The antioxidative and antihistaminic effect of Nigella sativa and its major constituent, thymoquinone on ethanol-induced gastric mucosal damage. Arch Toxicol 2006;80: 217-24.
35. Gebbers JO, Ferguson DJ, Mason C, Kelly P, Jewell DP. Spirochaetosis of the human rectum associated with an intraepithelial mast cell and IgE plasma cell response. Gut 1987;28:588-93.
36. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapteninduced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989;96:795-803.
37. Xu X, Weksler-Zangen S, Pikarsky A, Pappo O, Wengrower D, Bischoff SC et al. Mast cells involvement in the inflammation and fibrosis development of the TNBS-induced rat model of colitis. Scand J Gastroenterol 2002;37:330-7.
38. Fukumoto Y, Kasai H, Takahashi H, Sugiyama H, Hase N, Kaneko H et al. The role of mast cells in the development of 2, 4, 6-trinitrobenzene sulfonic acid-induced colitis in rats. Scand J Gastroenterol 2002;37:555-60.